Carisma Therapeutics Information
Contact top employees from
Carisma Therapeutics
Summary
Carisma Therapeutics is a private company that has been in the industry for 9 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the President & CEO is occupied by Steven Kelly. Its headquarters is located at Philadelphia, Pennsylvania, USA. The number of employees ranges from 25 to 100. The annual revenue of Carisma Therapeutics varies between 100K and 5.0M. Total funding of the company - $121.9M. To connect with Carisma Therapeutics employee register on SignalHire.
Organization Website | carismatx.com |
Social Links |    |
Phone Number | 484-899-0326 |
Industries | |
Headquarters Location | 3675 Market St, Ste 401, Philadelphia, Pennsylvania, 19104 US |
Employees Size | 100-200 employees |
SIC Code | 2836 |
DMA Code | Delaware Valley |
Founded | 2016 |
Estimated Annual Revenue | $100K - 5.0M |
Operating Status | Independent Company |
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2008 | Privately Held | 250 - 500 | 40.9M | $923.3M | |
| 2015 | Public Company | 100 - 250 | < 1M | $269.5M | |
| 2008 | Public Company | 250 - 500 | 3.6M | $358.7M | |
| 2000 | Public Company | 100 - 250 | 38.4M | $361.3M |
Estimated Website Traffic
The chart shows a decline in traffic to the carismatx.com website. In November, traffic decreased to 6500, compared to 6973 in the previous month. The highest traffic in 2025 was recorded in October, reaching 6973 visits.
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Length of Employment
Employee tenure at Carisma Therapeutics shows a diverse range of experience levels:
15% have been with the company for less than 1 year22% for 1–2 years15% for 3–4 years33% for 5–7 years7% for 8–10 years7% have over 11 years of service at Carisma TherapeuticsEx-employees positions
In Company
In New Company
Contact top employees from
Carisma Therapeutics
Steven Kelly
President and Chief Executive Officer
Dora Mitchell
Vice President, Operations
Sascha Abramson
Vice President, Scientific Operations
Adam Pfendt
Senior Director Process Development
Hameem Mazahreh
Senior Manager, Quality Assurance
Poonam Sonawane
Senior Scientist/Senior Manager
Ashley Mattson
Associate Scientist
Nicholas Minutolo
Associate Director, Research
Nancy Leigh Carson
Histologist
Vishal Khatri
Senior Scientist, Discovery
David Christopher Sloas
Associate Director of Fibrosis R&D
Sabrina Ceeraz DeLong
Scientific Writer
Elena Petrossian
Senior Director, Financial Controller
Michael Klichinsky
Co-Founder and Chief Scientific Officer
Joanna Schmidt
Associate Director - Scientific Operations
Stefano Pierini
Associate Director
Brett Menchel
Scientist / Senior Associate Scientist
Vasiliki Pappa
Scientist
Daniela Burnes Vargas
Associate Scientist
Robert Saporito
Senior Associate Scientist
Kara Collins
Office Manager
Jennifer Wetzler
Senior Project Manager
Angela Mosebarger
In vitro Associate Scientist
Hughes Joe
Distinguished Carisma Development Fellow
Crystal Griffin
Associate Scientist
Andrew Best
Manager, Process Development
Anna Betron
Process Development Scientist
Brad Zinker
Senior Director, Research
Jordan Reff
Senior Associate Scientist
Similar Companies
FAQ
Carisma Therapeutics operates in the Biotech industries. More details can be found on the official website: carismatx.com.
The headquarters of Carisma Therapeutics are located in Philadelphia, United States.
The current CEO of Carisma Therapeutics is Steven Kelly
You can contact Carisma Therapeutics by phone at 484-899-0326.
Carisma Therapeutics currently employs 100-200 people.
Carisma Therapeutics's revenue is approximately 2M.
Well-known competitors of Carisma Therapeutics include Immunocore, TCR² Therapeutics Inc., Adaptimmune and Immatics.
